#CryptoCorner: BTC Recovers $10K Support before Weekend, China Recognizes #Bitcoin as ‘Virtual Property’, Bundesbank President Praises Libra and Binance Jersey Lists GBP-Backed Stablecoin

#CryptoCorner: BTC Recovers $10K Support before Weekend, China Recognizes #Bitcoin as ‘Virtual Property’, Bundesbank President Praises Libra and Binance Jersey Lists GBP-Backed Stablecoin

Point Roberts, WA, Delta BC July 19, 2019 - Investorideas.com, a leader in crypto and blockchain investing news, in partnership with Fit Pay, Inc.’s  (subsidiary of NXT-ID (NASDAQ: NXTD) crypto payment tech, Flip and  the Genesis Exchange and Wallet  App bring you today’s edition of the Crypto Corner podcast and commentary on what’s driving the cryptocurrency market .

Listen to today’s Crypto Corner Podcast:  

https://www.investorideas.com/Audio/Podcasts/2019/071919-CryptoMarket.mp3

Read this in full at

https://www.investorideas.com/news/2019/crypto-corner/07191BTC-China-Bundesbank-Binance.asp

Get the Crypto Corner Podcast on iTunes

Subscribe to Podcast RSS feed:

https://www.investorideas.com/rss/feeds/Podcasts-Crypto.xml

July 19 Crypto Corner

Stocks discussed: (NasdaqGS:FB)

As we head into another weekend the crypto market appears to be experiencing a mild recovery, with Bitcoin (BTC) and most of the top 100 listed altcoins in the green today, according to data from CoinMarketCap. Bitcoin itself is posting growth of about 6 percent in the last 24 hours, bringing the current trading price to $10,370 – once again back over the $10,000 support level, after dipping below it earlier this week. Bitcoin is still enjoying considerable market dominance, accounting for 65.8 percent of the entire crypto market with a market cap of $185 billion. Ether (ETH) remains the top altcoin, but after only posting a 24-hour growth of 1.35 percent, it only boasts a market cap of $23 billion. The crypto market’s total market cap is currently $280 billion.

According to a tweet by Dovey Wan, a founding partner of crypto asset fund Primitive, China now legally regards Bitcoin as property. The tweet cited an article from a local media outlet, which indicated that the Hangzhou Internet Court classified Bitcoin as “virtual property”. This was corroborated by a report from Global Times, which quotes an unnamed official of the People's Bank of China (PBC):

"Indeed, Bitcoin is virtual property, but it's not fiat money.”

Cao Yin, an expert in the blockchain sector, told the Global Times:

"This is a clear signal that the financial authorities are starting to loosen control over digital currency and virtual currency."

Cao went on to comment on the significance in understanding cryptocurrencies like Bitcoin in order to contend with Facebook’s (NasdaqGS:FB) Libra.

"Libra is a financial asset based on multiple financial products and is also partly based on the value chain of Bitcoin. Careful study of Bitcoin is necessary for the PBC to face changes in the financial market caused by Libra."

On the subject of Libra, the forthcoming crypto project has seen the emergence of an unexpected defender. Mati Greenspan, a senior analyst for eToro, revealed via Twitter that the president of Germany’s central bank has come out in favour of Libra. The Bundesbank President Jens Weidmann “warned against inadvertently suppressing innovative concepts before all details have been clarified”.

“If they deliver what they promise, they can be attractive to consumers. Who wants to source must swim against the current.”

According to Cointelegraph, fiat-crypto exchange Binance Jersey has listed a proprietary British pound-backed stablecoin. Binance Chief Financial Officer Wei Zhou told the publication that:

“There has been an overwhelming demand in the market and Binance community for more stablecoin diversification, including a GBP-pegged stablecoin.”

Sam Mowers, Investorideas

Read other editions of the  Crypto Corner

Get the Crypto Corner News by email Get Crypto Corner News

Crypto Corner Sponsors:

Flip™ is the creation of Fit Pay, Inc., a leading provider of cutting edge payment technology and a subsidiary of NXT-ID (NASDAQ: NXTD). By leveraging the FitPay Payment Platform™, Flip enables cryptocurrency holders to seamlessly exchange their cryptocurrency for US dollars and store that value on a contactless payment device that can be used to make purchases at millions of retail locations.  https://www.fliptopay.com/

Order Flip    

Genesis Exchange and Wallet App by Genesis Blockchain Technologies ( GBT)

@GenesisBlockch  , @GbtTechnologies

GBT is a powerful cryptocurrency centralized / decentralized exchange which will include a broad range of services and benefits from cryptocurrency and blockchain markets development, while avoiding complications and risks arising from crytocurrency ownership, transfer, and exchange.You can Download the Genesis Exchange and Wallet App at Google Play and on the Apple App Store. Learn more at  http://www.mygenesis.io

More info on the sector:

Investor Ideas is positioning as a  leader in blockchain and crypto content with its Bitcoin and Blockchain portals Bitcoinandblockchainstocks.com, Cryptocurrencyinvestorideas.com and Blockchaininvestorideas.com

For investors following the sector Investor Ideas has a comprehensive Bitcoin, Blockchain and Digital Currency Stocks Directory

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

The Crypto Corner is part of the Investor Ideas Membership content

The Investorideas.com podcasts are also available on iTunes,  Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: this newsletter and podcast is sponsored content by featured companies NXt-ID (NASDAQ: NXTD) on behalf of Flip and GBT Technologies . More info: http://www.investorideas.com/About/News/Clientspecifics.asp

Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Cryptocurrency Disclaimer

Investorideas.com news content is not meant to be a solicitation to buy or sell cryptocurrencies and Investorideas.com does not directly sell cryptocurrencies; but acts as a news and research resource for interested investors following the blockchain sector.

Copyright and ownership: Crypto Corner is an Investorideas.com content brand

Learn more about our news, PR and social media services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Contact Investorideas.com

800-665-0411

Get more Bitcoin and Blockchain Investor ideas  – news, articles, podcasts and stock directories 

Investor Ideas Adds Recent IPO’s in #Biotech (NASDAQ: $PSNL) (NASDAQ: $STOK), #Tech (NASDAQ: $SONM) and #Defense (NYSE: $PSN)

Investor Ideas Adds Recent IPO’s in #Biotech

(NASDAQ: $PSNL) (NASDAQ: $STOK), #Tech (NASDAQ: $SONM) and #Defense (NYSE: $PSN)

Point Roberts WA, Delta BC, July 19, 2019 – (Investorideas.com Newswire) Investorideas.com, a global news source and leading investor resource announces this week’s additions to its global stock directories in biotech, tech and defense.

Read this in full at https://www.investorideas.com/news/2019/main/07191Stocks.asp

This week’s new additions are all recent Nasdaq IPO’s with the majority in the biotech sector.

New biotech companies include biopharma firms, life sciences companies and drug development companies working on treatments for cancer, diabetes, heart disease, genetic disorders, neurologic disorders and others.

The latest tech companies include a Russian online job recruitment platform and a company designing ultra-rugged mobility solutions.

The newest defense stock, PARSONS CORP. (NYSE:PSN) is a leading provider of tech solutions focused on the defense, intelligence and critical infrastructure markets and is also involved in cyber security solutions, thus crossing over onto the tech sector stock list as well.

New Biotech Companies:

PERSONALIS, INC. (NasdaqGM:PSNL) is a growing cancer genomics company transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. The company’s NeXT™ Platform is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue sample. The Personalis Clinical Laboratory is GxP aligned as well as CLIA’88-certified and CAP-accredited.

STOKE THERAPEUTICS, INC. (NasdaqGS:STOK) is a biotechnology company that is pioneering a new way to treat the underlying causes of severe genetic diseases by precisely upregulating protein expression to restore target proteins to near normal levels. Stoke aims to develop the first precision medicine platform to target the underlying cause of a broad spectrum of genetic diseases in which the patient has one healthy copy of a gene and one mutated copy that fails to produce a protein essential to health. These diseases, in which loss of approximately 50 percent of normal protein expression causes disease, are called autosomal dominant haploinsufficiencies. Stoke was launched with investments by Apple Tree Partners. Stoke is headquartered in Bedford, Massachusetts with offices in Cambridge, Massachusetts.

APPLIED THERAPEUTICS INC. (NasdaqGM:APLT) is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The company’s lead drug candidate, AT-001, is a novel aldose reductase inhibitor (ARI) that is being developed for the treatment of Diabetic Cardiomyopathy, or DbCM, a fatal fibrosis of the heart. The company plans to initiate a Phase 2/3 pivotal study in DbCM in 2019. Applied Therapeutics is also developing AT-007, a central nervous system penetrant ARI, for the treatment of Galactosemia, a rare pediatric metabolic disease, and initiated a Phase 1/2 clinical trial in June 2019. The preclinical pipeline also includes AT-003, an ARI designed to cross through the back of the eye when dosed orally, for the treatment of diabetic retinopathy, expected to advance into a Phase 1 study in 2020.

         

MILESTONE PHARMACEUTICALS INC. (NasdaqGS:MIST) headquartered in Montreal, Canada with a U.S. subsidiary in Charlotte, N.C., is a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing the investigational new drug etripamil for the treatment of cardiovascular indications. Etripamil is a novel, potent and short-acting calcium channel blocker designed by Milestone and being developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia (PSVT) as they occur.  

NEXTCURE, INC. (NasdaqGS:NXTC) is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases. Through our proprietary FIND-IO™ platform, we study various immune cells to discover and understand targets and structural components of immune cells and their functional impact in order to develop immunomedicines. Our initial focus is to bring hope and new treatments to patients who do not respond to current cancer therapies, patients whose cancer progresses despite treatment and patients with cancer types not adequately addressed by available therapies.

AXCELLA HEALTH INC. (NasdaqGM:AXLA) is designing and developing AXA Candidates, compositions of endogenous metabolic modulators, or EMMs, engineered in distinct ratios, designed to target and maximize the fundamental role that EMMs play in regulating multiple metabolic functions. Axcella’s AXA Candidates are generated from its proprietary, human-focused AXA Development Platform. Axcella believes its expertise and capabilities in EMMs position it to become a preeminent biotechnology company reprogramming metabolism to address a diverse set of complex diseases and support health. Axcella’s AXA Development Platform has already produced a pipeline of product candidates in programs targeting liver, muscle and blood. Axcella was founded by Flagship Pioneering.

CORTEXYME, INC. (NasdaqGS:CRTX) is a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat a key underlying cause of Alzheimer’s disease and other degenerative diseases. Cortexyme is targeting a specific, infectious pathogen found in the brain of Alzheimer’s patients and tied to neurodegeneration and neuroinflammation in animal models. The company’s lead investigational medicine, COR388, is the subject of the GAIN trial, an ongoing Phase 2/3 clinical study in patients with mild to moderate Alzheimer’s disease.

                             

TREVI THERAPEUTICS, INC. (NasdaqGM:TRVI) is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. Trevi is currently developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and levodopa-induced dyskinesia (LID) in patients with Parkinson’s disease. These conditions share a common pathophysiology that is mediated through opioid receptors in the central and peripheral nervous systems. Trevi is currently conducting a Phase 2b/3 clinical trial of nalbuphine ER, referred to as the PRISM trial, in patients with severe pruritus associated with prurigo nodularis.

AVANTOR, INC. (NYSE:AVTR) is a leading global provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. We operate in more than 30 countries and deliver an extensive portfolio of products and services. We set science in motion to create a better world.

         

TRANSMEDICS GROUP, INC. (NasdaqGM:TMDX) is the world’s leader in portable ex-vivo warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung and liver failure.

New Tech Companies:

HEADHUNTER GROUP PLC (NasdaqGS:HHR) is the leading online recruitment platform in Russia and CIS focusing on facilitating the recruitment process and connecting millions of job seekers with hundreds of thousands of employers annually. HeadHunter is one of the most visited job and employment website globally, our CV database contains 36.2 million CVs and our platform hosts a daily average of more than 559,000 job postings.

SONIM TECHNOLOGIES INC (NasdaqGM:SONM) s a leading U.S. provider of ultra-rugged mobility solutions designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The Sonim solution includes ultra-rugged mobile phones, a suite of industrial-grade accessories, and data and workflow applications which are collectively designed to increase worker productivity, communication and safety on the job site.

New Defense Companies:

PARSONS CORP. (NYSE:PSN) is a leading provider of technology-driven solutions focused on the defense, intelligence, and critical infrastructure markets. Celebrating 75 years of operations, Parsons provides technical design and engineering services and software products to address our customers' challenges. Parsons has differentiated capabilities in cybersecurity, intelligence, missile defense, space, connected communities, physical infrastructure, and mobility solutions. Parsons' combination of talented professionals and advanced technology enables a safer, smarter, and more interconnected world.

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

To sponsor a daily podcast for the month or to be an expert guest please contact us!

Contact Investorideas.com

800-665-0411

Trend Alert-Desserts are Becoming Healthier: Vegan, Low Sugar and CBD (OTC: $ARSN) ( $WMT) (NYSE: $KR) (CSE: $CURA.C) (OTCQX: $CURLF)

Trend Alert-Desserts are Becoming Healthier: Vegan, Low Sugar and CBD (OTC: $ARSN) ( $WMT) (NYSE: $KR) (CSE: $CURA.C) (OTCQX: $CURLF)

Point Roberts, WA and Delta, BC - July 19, 2019 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering food and Lifestyles of Health and Sustainability (LOHAS) stocks releases a snapshot reporting on the continued trend towards healthier ice cream alternatives such as vegan, low fat/sugar and eventually CBD infused.

In recent news, IndexBox published a new report, “The U.S. Ice Cream And Frozen Dessert Market. Analysis And Forecast to 2025”. According to the report, the ice cream market in the US amounted to $8.1B in 2018, leveling off at the previous year.

Within those sales, high protein/light ice cream is became one of the largest selling segments of the marketplace, beginning to outsell even Ben and Jerry's gourmet ice cream.

Aureus, Inc. (OTC: ARSN), www.AureusNOW.com, a food brand development company that exclusively operates the online sales of Yuengling’s Ice Cream brand, as well as select Yuengling retail distribution, today announced that it was returning 250mm shares of common stock to its treasury.

Read this in full at

https://www.investorideas.com/news/2019/cannabis/07191Stocks-Trend.asp

”We were able to complete the transaction with Yeungling’s using a restricted class of preferred shares in lieu of the common that we issued for that purpose. This is a much better structure for the company and its shareholders,” according to Aureus CEO, Everett Dickson.

Aureus recently completed the acquisition of Yuengling's Ice Cream and announced the new flavors in development which are Gourmet Vanilla, Gourmet Chocolate, Mint Chocolate Chip, Peanut Butter, Cookies & Cream, Salted Caramel, Gourmet Strawberry and Black & Tan.

With approximately 90 calories per serving, Yuengling's high protein/lite ice cream is packed with protein but low in fat, carbohydrates and sugar. "Unlike most high protein products on the market, our lite ice cream tastes like our super premium product," said David Yuengling, President of Yuengling's Ice Cream. "In fact, our Vanilla Lite Ice Cream won a gold medal and our Chocolate Lite Ice Cream was awarded a bronze medal in the LA International Dairy competition."

Yeungling’s ice cream is also available to consumers in a large, well- known retailer who has begun endorsing healthier ice cream options; Walmart (NYSE:WMT). 

Walmart Inc. (NYSE:WMT), may be further behind then companies such as CVS and Whole Foods who have been focusing on CBD and wellness products for the past several months, but according to recent news, “the biggest pharmaceutical chains such as Target and Walmart aren’t stocking up on CBD just yet, but they’re definitely getting ready for when the day comes.”

The Post recently learned that top executives at Walmart and Target have been discreetly meeting with CBD companies, though Walmart announced that as of yet, they do not have plans to carry CBD products at this time.

CBD may still be a little ways off from entering mainstream retail but products like Yeungling’s, a healthier alternative ice cream is already hitting shelves.

In related news, The Kroger Co. (NYSE:KR) was also mentioned as looking to enter into this sector with its Deluxe Unicorn Swirl Ice Cream and other store-brand products to boost growth, Chief Executive Rodney McMullen said on Thursday.

"We know we can do better when it comes to identical sales results," McMullen told analysts after Kroger posted quarterly same-store sales below Wall Street estimates, sending its shares down 2.5%.

Kroger's brand sales for the quarter rose 3.3% with Unicorn Ice Cream, Pork Belly Bites and Artesian Jerky among the 219 new store brand items that boosted sales by $225 million.

"Kroger has been very clever about expanding into rapidly growing categories," said Neil Saunders, who heads retail consultancy firm, GlobalData, “highlighting brands like Simple Truth and Home Chef meal kits.”

Kroger’s Simple Truth line has also seen success, having hit $2.3 billion in annual sales to become the biggest US natural and organic brand. Simple Truth has benefited from a social media boost. Kayla Schneider, a 28 year-old vegan receptionist and beauty advisor from Fenton, Michigan, who has 11,000 Twitter followers earlier this year tweeted when Simple Truth vegan ice cream went on sale.

“I have a lot of followers who also share my type of diet and I like sharing new finds/yummy products so they can try them out as well,” Schneider said in a Twitter direct message.

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), is also showing interest with their recent announcement of two separate acquisitions in Arizona for a combined consideration of $25.5 million.

Curaleaf entered into an agreement to acquire Glendale Greenhouse, a vertically integrated cannabis business operating a cultivation and processing facility along with a prime retail location, with plans to rebrand as Curaleaf after the transaction closes.

The Glendale Greenhouse production facility is a 20,000 square-foot, multi-level cultivation center which is capable of producing 3,600 pounds of flower annually. Its 1,500 square-foot dispensary, located directly off the Agua Fria Freeway with 90,000 cars passing daily, can be expanded to nearly 5,000 square-feet. Glendale Greenhouse holds the master lease on the 15,000 square-foot multi-tenant building where the dispensary is located. The facility also operates a state-of-the-art CO2 extraction lab and a kitchen, which is already producing various edible lines such as mints, gummies, brownies and ice cream, with additional products expected to launch later this year.

Additionally, Curaleaf agreed to acquire Phytotherapeutics Management Services, LLC, which operates under the license of Phytotherapeutics of Tucson, LLC. Upon close of the transaction, the license associated with the dispensary will be applied to a newly developed flagship dispensary, located at 2175 N. 83^rd Avenue, which is part of an exciting Phoenix metro submarket with close access to the I-10 Freeway. The dispensary will also be in the immediate vicinity of the nationally recognized Ak-Chin Pavilion, a popular outdoor amphitheater and concert stadium hosting nearly forty events a year. This new location on 83^rd Avenue will bring Curaleaf's store count in Arizona to eight, all in Maricopa County.

According to US Census Bureau data, Maricopa is the nation's fastest growing county for the third consecutive year, giving Curaleaf the highest store count in the County.

"The acquisition of both Glendale Greenhouse and the opening of our 83^rd Avenue location demonstrate our commitment to the Arizona market and to providing consumers with reliable and high-quality cannabis experience," said Joseph Lusardi, Chief Executive Officer.

"This transaction not only strengthens our position with the seventh and eighth Curaleaf branded dispensaries in the fast-growth Phoenix metro market, but greatly enhances our processing capabilities and accelerates our plans to produce and distribute wholesale products in the state."

While the US ice cream market may not be expanding rapidly in terms of dollar growth, the product offerings are going through a massive change. Fading are the days of unhealthy/high fat and sugar ice creams as wellness, health, and of course CBD trends sweep the nation.

For investors following food and beverage stocks and LOHAS stocks, InvestorIdeas.com has created stock directories to research each sector. Learn more about our membership and directories: https://www.investorideas.com/membership/  

About Investorideas.com - News that Inspires Big Investing Ideas

https://www.investorideas.com/About/

Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Disclaimer/Disclosure: Investorideas.com. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: This industry article featuring ARSN is a paid for service on Investorideas( two thousand) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Contact Investorideas.com

800-665-0411

AI News: VSBLTY (CSE: $VSBY.C) (OTC: $VSBGF) Announces Closing of Convertible Debenture Offering

AI News: VSBLTY (CSE: $VSBY.C) (OTC: $VSBGF) Announces Closing of Convertible Debenture Offering

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES

Philadelphia, PA - July 19, 2019 (Investorideas.com Newswire) VSBLTY Groupe Technologies Corp. (CSE: VSBY) (5VS.F) (VSBGF) ("VSBLTY" or the "Company") is pleased to announce that it has closed a non-brokered private placement offering of convertible debenture ("Debentures") for gross proceeds of CAD $745,500 (the "Offering").

Read this in full at https://www.investorideas.com/CO/VSBY/news/2019/07191ConvertibleDebenture.asp

The Debentures bear interest at 10% per annum on an accrual basis, calculated and payable semi-annually, maturing on July 18, 2021 (the "Maturity Date") that is 24 months from the date of issuance on July 18, 2019 (the "Closing Date").

The Debentures, together with any interest accrued but unpaid, may be convertible, in whole or in part, at any time before the Maturity Date, into units of the Company (each, a "Unit") at $0.45 per Unit, if converted at any time before one year from the Closing Date, or otherwise convertible at $0.60 per Unit if converted after one year from the Closing Date but before the Maturity Date.

Each Unit consists of one common share in the capital of the Company (a "Share") and one-half of a Share purchase warrant (each whole warrant, a "Warrant"). Each Warrant will be exercisable into one Share (each a, "Warrant Share") at a price of $0.60 per Warrant Share for a period of 24 months from the Closing Date, subject to acceleration. The Company may exercise its warrant acceleration right, if on any ten consecutive trading days, beginning on the date that is four months and one day following the Closing Date, the closing price of the Company's Shares on the CSE is greater than $1.00 per Share. If the Company exercises its warrant acceleration right, the new expiry date of the Warrants will be the 30th day following the notice of such exercise.

The net proceeds from the Offering will be used for acquisitions and general and corporate working capital purposes.

The Debentures are subject to a statutory four month and one day hold period, which expires on November 19, 2019.

Guy Lombardo, a director of the Company, and Jay Hutton, the CEO and a director of the Company, purchased Debentures in the principal amounts of $327,500 and $25,000, respectively, under the Offering. These purchases each constituted a "related party transaction" within the meaning of Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101"). These issuances to insiders are exempt from the formal valuation and the minority shareholder approval requirements of MI 61-101 as the fair market value of the Debentures issued to or the consideration paid by such person did not exceed 25% of the Company's market capitalization.

In accordance with the terms of a merger agreement dated December 12, 2018 between the Company, VSBLTY Merger Co. and VSBLTY Inc., common shares in the capital of VSBLTY issued to former VSBLTY, Inc. shareholders and former holders of VSBLTY, Inc. debentures are subject to voluntary hold periods. The Company has received commitments from approximately 82% of such shareholders to extend the voluntary hold periods for a period of three months.

The Company is not proceeding with the unit offering it previously announced on May 8, 2019.

The securities referred to in this news release have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent U.S. registration or an applicable exemption from the U.S. registration requirements. This release does not constitute an offer for sale of, nor a solicitation for offers to buy, any securities in the United States. Any public offering of securities in the United States must be made by means of a prospectus containing detailed information about the issuer and its management, as well as financial statements.

On Behalf of the Board of VSBLTY Groupe Technologies Inc.

"Jay Hutton"

CEO & Director

Investor Relations
MarketSmart Communications Inc., +1 877 261-4466info@marketsmart.ca

CONTACT: Linda Rosanio, 609-472-0877lrosanio@vsblty.net

About VSBLTY (www.vsblty.net)

Headquartered in Philadelphia, VSBLTY (CSE: VSBY) (Frankfurt: 5VS) (OTCBB:VSBGF) is the world leader in Proactive Digital Display™, which transforms retail and public spaces as well as place-based media networks with SaaS-based audience measurement and security software that uses artificial intelligence and machine learning.

The CSE does not accept responsibility for the adequacy or accuracy of this release.

FORWARD LOOKING STATEMENT

This news release contains forward-looking statements, including statements regarding the attributes of the securities to be offered and sold by the Company, the proposed use of the net proceeds of the Offering, the closing date of the Offering and the future price of the Shares on the Canadian Securities Exchange, and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, and which are described in the Company's public filings available under its profile at www.sedar.com. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company does not intend to update any of the included forward-looking statements except as required by Canadian securities laws.

LINDA ROSANIO
VSBLTY, INC
609-472-0877LROSANIO@VSBLTY.NE

VSBLTY Groupe Technologies Corp. (CSE: VSBY) is a featured Tech / AI stock on Investorideas.com

Visit profile page

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: VSBLTY is a paid PR, news and social media client on Investorideas.com as of March 1, 2019  https://www.investorideas.com/About/Disclaimer.asp

Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

  

Get more tech stocks investor ideas- news, articles, podcasts and stock directories